24

DongBang Medical

240550 · KQ

5,580.00KRW+120.00 (+2.20%)

Price History

Full chart

Market Stats

Previous Close5,460.00
Open5,410.00
Day Range5,340.00 – 5,600.00
52-Week Range4,500.00 – 10,610.00
Volume65.67K
Market Cap291.47B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
50-Day Avg5,834.60
200-Day Avg6,755.80

About

Dongbang Medical Co., Ltd produces and sells medical devices, fillers, bio medical devices, and cosmetics devices in South Korea. It offers HA filler, a medical device used for improving facial wrinkles and volume recovery under the ELASTY GRAND, ELASTY DEEP PLUS, ELASTY G PLUS, ELASTY D PLUS, and ELASTY F PLUS names; threads under the ELASTY LINE, ELASTY MESHFILL, ELASTY-V BARB, ELASTY-V UP, ELASTY-V SCREW, and ELASTY-V MONO names; and cannula, needle, and syringe products. The company also provides Hyaluronic acid mask, Beta-Glucan mask, FILL US patch, AG Solution Calming Gel, AG Solution Defying Serum, AG Solution Defying Cream, AG Solution Regenerating PP Cream, AT Solution Clean Wash, AT Solution Moisturizing Lotion, AT Solution Concentrated Cream, AC Solution Clarifying Cleanser, AC Solution Refining Cel, AC Solution Moisturizing Lotion, Hair Solution Scalp Shampoo, Hair Solution Scalp Treatment, HA ESSENCE, and Hair Solution Scalp Tonic products; hand acupuncture, hand acupuncture tube, and spring hand acupuncture tube products; and pillow, charcoal, heat resistant silicone, heat reducing paper, pipe, frame, clay ring, cap, cupping, and other products. It exports its products to approximately 50 countries in North America, South America, Europe, Asia, and the Middle East. The company was founded in 1985 and is headquartered in Seongnam-si, South Korea.

Company Details

Leadership

  • Mr. Keun-Sik KimCEO & Director
  • Nak I ChoiExecutive Director

Earnings

Report DateMar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate------
EPS Actual152.3894.58141.04170.77256.65196.89
Surprise------
Timing------

Key Statistics & Ratios

Market Cap291.47B
Enterprise Value143.08B
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.00
Price / Book0.00
Revenue (TTM)125.12B
Gross Profit (TTM)45.58B
EBITDA28.57B
Profit Margin12.88%
Operating Margin17.88%
Return on Equity12.30%
Return on Assets7.05%
Shares Outstanding0
Shares Float9.59M
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%